About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Bupropion
- Procedure number
- PSUSA/00000461/202112
- Regulatory outcome
- Variation
Documents
Bupropion : List of nationally authorised medicinal products - PSUSA/00000461/202112
English (EN) (275.48 KB - PDF)
Bupropion : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00000461/202112
English (EN) (155.25 KB - PDF)
български (BG) (213.5 KB - PDF)
español (ES) (161.55 KB - PDF)
čeština (CS) (190.83 KB - PDF)
dansk (DA) (182.75 KB - PDF)
Deutsch (DE) (162.11 KB - PDF)
eesti keel (ET) (171.51 KB - PDF)
ελληνικά (EL) (183.97 KB - PDF)
français (FR) (143.73 KB - PDF)
hrvatski (HR) (221.65 KB - PDF)
íslenska (IS) (136.16 KB - PDF)
italiano (IT) (178.99 KB - PDF)
latviešu valoda (LV) (199.42 KB - PDF)
lietuvių kalba (LT) (210.66 KB - PDF)
magyar (HU) (208.05 KB - PDF)
Malti (MT) (222.47 KB - PDF)
Nederlands (NL) (140.59 KB - PDF)
norsk (NO) (134.42 KB - PDF)
polski (PL) (202.93 KB - PDF)
português (PT) (172.72 KB - PDF)
română (RO) (199.91 KB - PDF)
slovenčina (SK) (201.16 KB - PDF)
slovenščina (SL) (209.3 KB - PDF)
Suomi (FI) (138 KB - PDF)
svenska (SV) (159.01 KB - PDF)